Stomal calprotectin as a biomarker for assessing Crohn disease activity in patients with stomas
Stomal calprotectin did not reliably distinguish between active and inactive Crohn disease. C-reactive protein is a more reliable biomarker for disease activity in the setting of ileostomy/colostomy. Further prospective studies are needed to identify more robust biomarkers for detecting inflammation in stoma patients.
Authors
- Kate D. Lynch (ORCID: https://orcid.org/0000-0001-7748-2165)
- Jane M. Andrews (ORCID: https://orcid.org/0000-0001-7960-2650)
- Simon Ghaly (ORCID: https://orcid.org/0000-0003-2489-6430)
- Susan J. Connor (ORCID: https://orcid.org/0000-0001-5606-0270)
- Martin Harb (ORCID: https://orcid.org/0000-0001-6288-1788)
- Karen Bensted (ORCID: https://orcid.org/0000-0002-4830-0788)
- Kavindra Abeyratne (ORCID: https://orcid.org/0009-0007-7177-1207)
Institutions
- Royal Adelaide Hospital (AU)
- Liverpool Hospital (AU)
- UNSW Sydney (AU)
- St Vincent's Hospital Sydney (AU)
- St Vincent's Clinic (AU)
- The University of Adelaide (AU)
Publication Details
- Journal
- Internal Medicine Journal
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1111/imj.16648
- Citations
- 1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.82